Pathological findings in organs and tissues of patients with COVID-19: A systematic review
S Peiris, H Mesa, A Aysola, J Manivel, J Toledo… - PloS one, 2021 - journals.plos.org
Background Coronavirus disease (COVID-19) is the pandemic caused by SARS-CoV-2 that
has caused more than 2.2 million deaths worldwide. We summarize the reported pathologic …
has caused more than 2.2 million deaths worldwide. We summarize the reported pathologic …
Antivirals against coronaviruses: candidate drugs for SARS-CoV-2 treatment?
IA Santos, VR Grosche, FRG Bergamini… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses (CoVs) are a group of viruses from the family Coronaviridae that can infect
humans and animals, causing mild to severe diseases. The ongoing pandemic of severe …
humans and animals, causing mild to severe diseases. The ongoing pandemic of severe …
Coding long COVID: characterizing a new disease through an ICD-10 lens
Background Naming a newly discovered disease is a difficult process; in the context of the
COVID-19 pandemic and the existence of post-acute sequelae of SARS-CoV-2 infection …
COVID-19 pandemic and the existence of post-acute sequelae of SARS-CoV-2 infection …
[PDF][PDF] Dexamethasone for COVID-19? Not so fast
TC Theoharides, P Conti - J Biol Regul Homeost Agents, 2020 - researchgate.net
Recent announcements indicated, without sharing any distinct published set of results, that
use of the corticosteroid dexamethasone in a large trial in the UK apparently reduced …
use of the corticosteroid dexamethasone in a large trial in the UK apparently reduced …
[图书][B] Canine and feline endocrinology-e-book
EC Feldman, RW Nelson, C Reusch… - 2014 - books.google.com
NEW! Updated content includes the latest information on: thyroid disease; current imaging
studies; atypical Addison's disease; atypical Cushing's disease; idiopathic hypercalcemia in …
studies; atypical Addison's disease; atypical Cushing's disease; idiopathic hypercalcemia in …
[HTML][HTML] Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
COVID-19 is announced as a global pandemic in 2020. Its mortality and morbidity rate are
rapidly increasing, with limited medications. The emergent outbreak of COVID-19 prompted …
rapidly increasing, with limited medications. The emergent outbreak of COVID-19 prompted …
A blinded, randomized, placebo‐controlled, dose determination trial of lokivetmab (ZTS‐00103289), a caninized, anti‐canine IL‐31 monoclonal antibody in client …
GM Michels, DS Ramsey, KF Walsh… - Veterinary …, 2016 - Wiley Online Library
Background Pruritus is the hallmark clinical sign of atopic dermatitis (AD) in dogs.
Lokivetmab, a caninized anti‐canine IL‐31 monoclonal antibody, reduced pruritus and …
Lokivetmab, a caninized anti‐canine IL‐31 monoclonal antibody, reduced pruritus and …
Formulation development and characterization of dual drug loaded hot-melt extruded inserts for better ocular therapeutic outcomes: Sulfacetamide/prednisolone
The present investigation was intended to formulate and evaluate a hot-melt extruded (HME)
bioadhesive ophthalmic inserts containing a fixed-dose combination of Prednisolone …
bioadhesive ophthalmic inserts containing a fixed-dose combination of Prednisolone …
Upper and lower respiratory tract microbiota in horses: bacterial communities associated with health and mild asthma (inflammatory airway disease) and effects of …
Background The microbial composition of the equine respiratory tract, and differences due to
mild equine asthma (also called Inflammatory Airway Disease (IAD)) have not been …
mild equine asthma (also called Inflammatory Airway Disease (IAD)) have not been …
Glucocorticoid therapy: pharmacology, indications, and complications
EN Behrend, RJ Kemppainen - Veterinary Clinics of North America: Small …, 1997 - Elsevier
Glucocorticoids are one of the most commonly prescribed classes of medication in
veterinary medicine, with numerous applications ranging from physiologic replacement …
veterinary medicine, with numerous applications ranging from physiologic replacement …